|
PGGT1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.362800E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.422200E-02 |
| Normal-vs-Stage2 |
5.518800E-01 |
| Normal-vs-Stage3 |
7.581600E-03 |
| Normal-vs-Stage4 |
3.75670000000161E-05 |
| Stage1-vs-Stage2 |
7.601400E-01 |
| Stage1-vs-Stage3 |
1.181180E-01 |
| Stage1-vs-Stage4 |
1.160900E-03 |
| Stage2-vs-Stage3 |
2.778400E-01 |
| Stage2-vs-Stage4 |
6.616100E-02 |
| Stage3-vs-Stage4 |
1.721230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.912310E-02 |
| Normal-vs-AfricanAmerican |
7.443300E-04 |
| Normal-vs-Asian |
1.562380E-01 |
| Caucasian-vs-AfricanAmerican |
4.569600E-02 |
| Caucasian-vs-Asian |
6.450400E-01 |
| AfricanAmerican-vs-Asian |
8.727000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.598300E-03 |
| Normal-vs-Female |
7.196100E-02 |
| Male-vs-Female |
3.537000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.281800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.124400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.766370E-02 |
| Normal-vs-Age(81-100Yrs) |
1.706200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.560650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.178400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.354600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.364400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.293800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.601800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.558600E-01 |
| Normal-vs-Grade 2 |
3.669200E-01 |
| Normal-vs-Grade 3 |
1.343940E-03 |
| Normal-vs-Grade 4 |
4.23210000000118E-06 |
| Grade 1-vs-Grade 2 |
9.776000E-01 |
| Grade 1-vs-Grade 3 |
2.577400E-01 |
| Grade 1-vs-Grade 4 |
2.864100E-02 |
| Grade 2-vs-Grade 3 |
2.036300E-02 |
| Grade 2-vs-Grade 4 |
9.79819999999965E-05 |
| Grade 3-vs-Grade 4 |
1.911870E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.698400E-01 |
| Normal-vs-ccB subtype |
8.407700E-04 |
| ccA subtype-vs-ccB subtype |
1.409110E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.470300E-02 |
| Normal-vs-N1 |
4.605800E-02 |
| N0-vs-N1 |
4.112200E-01 |
|
|
